Real-world effectiveness of oral antivirals for COVID-19.

Authors:
Burdet C; Ader F.

Journal:
Lancet

Publication Year: 2022

DOI:
10.1016/S0140-6736(22)01929-8

PMCID:
PMC9539533

PMID:
36215994

Journal Information

Full Title: Lancet

Abbreviation: Lancet

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CB reports consulting fees from Da Volterra and Mylan and from 4Living Biotech (member of a data safety monitoring board for a clinical trial [LEONARDO] to investigate the effect of plerixafor in acute respiratory failure related to COVID-19), which are all unrelated to the topic of this Comment. FA declares no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025